Skip to main content

Allergan Plc (AGN-N) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 183.22
Day High 184.92
Open:183.45
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
- PR Newswire - Mon Nov 18, 7:00AM CST
PR Newswire - CMTX
Mon Nov 18, 7:00AM CST
AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance, LLC ("Allergan Finance"), Allergan, Inc. ("Allergan Inc"), Allergan Sales, LLC ("Allergan Sales") and Allergan Funding SCS ("Allergan Funding" and, together with Allergan Finance, Allergan Inc and Allergan Sales, "Allergan") (the "Allergan Notes") for new notes to be issued by AbbVie (the "AbbVie Notes") and the related consent solicitations (each, a "Consent Solicitation" and, collectively, the "Consent Solicitations") being made by AbbVie on behalf of Allergan to adopt certain amendments to each of the indentures (each, an "Allergan Indenture") governing the Allergan Notes. AbbVie hereby extends such expiration date from 11:59 p.m., New York City time, on November 22, 2019 to 5:00 p.m., New York City time, on December 31, 2019 (as the same may be further extended, the "Expiration Date").
Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day
- PR Newswire - Mon Nov 18, 6:30AM CST
PR Newswire - CMTX
Mon Nov 18, 6:30AM CST
Allergan plc (NYSE: AGN), the maker of BOTOX® Cosmetic, has announced the first-ever National BOTOX® Cosmetic Day kicking off on November 20. The celebration recognizes the impact this iconic aesthetic brand, which is the #1 selling treatment of its kind1, has had on American cultural conversation. Just in time for the holiday season, National BOTOX® Cosmetic Day is a moment to engage loyal consumers and healthcare providers, as well as those considering treatment, in a conversation about owning their look, with fewer lines, with BOTOX® Cosmetic. BOTOX® Cosmetic is the only treatment of its kind that is FDA approved for temporary improvements in moderate to severe crow's feet, frown lines, and forehead lines in adults.
Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day
- PR Newswire - Mon Nov 18, 6:30AM CST
PR Newswire - PRNW
Mon Nov 18, 6:30AM CST
DUBLIN , Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX ® Cosmetic, has announced the first-ever National BOTOX ® Cosmetic Day kicking off on November 20 . The celebration recognizes the impact this iconic aesthetic brand, which is the #1 selling treatment of its kind 1 , has had on American cultural conversation. Just in time for the holiday season, National BOTOX ® Cosmetic Day is a moment to engage loyal consumers and healthcare providers, as well as those considering treatment, in a conversation about owning their look, with fewer lines, with BOTOX ® Cosmetic. BOTOX ® Cosmetic is the only treatment of its kind that is FDA approved for temporary improvements in moderate to severe crow's feet, frown lines, and forehead lines in adults.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 172.97 +6.69% increase
on 10/24/19
Period Open:173.60
Price movement based on the high, low and last over the given period.
184.92 -0.20% decrease
on 11/18/19
+10.95 (+6.31%) increase
since 10/18/19
3-Month 158.31 +16.58% increase
on 08/23/19
Period Open:158.25
Price movement based on the high, low and last over the given period.
184.92 -0.20% decrease
on 11/18/19
+26.30 (+16.62%) increase
since 08/16/19
52-Week 114.27 +61.50% increase
on 06/17/19
Period Open:157.39
Price movement based on the high, low and last over the given period.
184.92 -0.20% decrease
on 11/18/19
+27.16 (+17.26%) increase
since 11/16/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).